Daniela (Hrsg.) Galimberti

Neurodegenerative Diseases

Clinical Aspects, Molecular Genetics and Biomarkers

Buch

This book gives an overview of the current knowledge on the most common neurodegenerative diseases, including Alzheimer's disease, frontotemporal lobar degeneration, Lewy body dementia,Parkinson's disease, amyotrophic lateral sclerosis, and additional less common neurodegenerative diseases. Both clinical and basic aspects of each disease are treated, including novel diagnostic criteria, old and new treatments, basic discoveries (genetics, epigenetics and molecular biology), and translation of basic research into biomarkers for early diagnosis, particularly to identify peripheral biomarkers. In addition, emerging data indicate that neurodegene… Mehr

CHF 223.00

Preise inkl. MwSt. und Versandkosten (Portofrei ab CHF 40.00)

Versandfertig innerhalb 1-3 Werktagen

V112: Lieferbar in ca. 10-20 Arbeitstagen

Produktdetails

Weitere Autoren: Scarpini, Elio (Hrsg.)

ISBN: 978-3-319-72937-4
EAN: 9783319729374
Produktnummer: 31952298
Verlag: Springer Nature EN
Sprache: Englisch
Erscheinungsjahr: 2018
Seitenangabe: 407 S.
Originaltitel: Neurodegenerative Diseases
Masse: H23.5 cm x B15.5 cm 7'492 g
Auflage: 2. A.
Abbildungen: schwarz-weiss Illustrationen, farbige Illustrationen, Tabellen, farbig
Gewicht: 7492
Sonstiges: Professional/practitioner

Über den Autor

Dr. Galimberti is the Secretary of the Dementia Panel of the European Academy of Neurology and the Italian Society for the research on dementia (Sindem).She is author of more than 250 scientific articles in international peer-reviewed journals, 10 chapters in international volumes, and more than 350 contributions to conferences. She serves as reviewer for several neurological journals. She is a Senior Associate Editor of the Journal of Alzheimer's disease.Elio Scarpini got his degree in Neurology in 1981 and he is professor of Neurology at the University of Milan. He is the Chief of the Alzheimer Center at the Policlinico University Hospital (Milan, Italy). His main interests include clinical and therapeutic aspects of neurodegenerative disorders (Alzheimer's disease, Frontotemporal Lobar Degeneration) and demyelinating diseases (Multiple Sclerosis).He is author of more than 300 scientific articles in international peer-reviewed journals and serves as reviewer for several neurological journals.